Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics

Molecular and Cellular Proteomics

Volumn 9, Issue 9, 2010, Pages 1991-2004

  Dos Santos, Alexandre ^a,b   Court, Magali ^a,c,d   Thiers, Valérie ^a,b,e   Sar, Sokhavuth ^a,b   Guettier, Catherine ^a,b,f   Samuel, Didier ^a,b   Bréchot, Christian ^a,b,g   Garin, Jérôme ^a,c,d   Demaugre, France ^a,b   Masselon, Christophe D ^a,c,d  

^a INSERM   (France)

^b Universite Paris Sud   (France)

^c DIF   (France)

^d UNIV GRENOBLE ALPES   (France)

^e INSTITUT PASTEUR   (France)

^f BICÊTRE HOSPITAL   (France)

^g Merieux Alliance   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VIMENTIN;

ACCURACY; ACTIN FILAMENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CARCINOGENESIS; CASE REPORT; CELL MOTILITY; CELL POPULATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MASS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; RELIABILITY; TISSUE MICROARRAY;

EID: 77956592441     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.000026     Document Type: Article

References (84)

1. Patel, T. (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33, 1353-1357
2. Ustundag, Y., and Bayraktar, Y. (2008) Cholangiocarcinoma: a compact review of the literature. World J. Gastroenterol. 14, 6458-6466
3. Ben-Menachem, T. (2007) Risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol. 19, 615-617
4. Blechacz, B. R., and Gores, G. J. (2008) Cholangiocarcinoma. Clin. Liver Dis. 12, 131-150, ix
5. El-Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C., and Giordano, T. P. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49, 116-123
6. Bonney, G. K., Craven, R. A., Prasad, R., Melcher, A. F., Selby, P. J., and Banks, R. E. (2008) Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol. 9, 149-158
7. Alpini, G., Invernizzi, P., Gaudio, E., Venter, J., Kopriva, S., Bernuzzi, F., Onori, P., Franchitto, A., Coufal, M., Frampton, G., Alvaro, D., Lee, S. P., Marzioni, M., Benedetti, A., and DeMorrow, S. (2008) Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res. 68, 9184-9193
8. Ohira, S., Itatsu, K., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Ishikawa, A., Oda, K., Nagasaka, T., Nimura, Y., and Nakanuma, Y. (2006) Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. Pathol. Int. 56, 381-389
9. Alvaro, D. (2009) Serum and bile biomarkers for cholangiocarcinoma. Curr. Opin. Gastroenterol. 25, 279-284
10. Farina, A., Dumonceau, J. M., and Lescuyer, P. (2009) Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev. Proteomics 6, 285-301
11. Nishino, R., Honda, M., Yamashita, T., Takatori, H., Minato, H., Zen, Y., Sasaki, M., Takamura, H., Horimoto, K., Ohta, T., Nakanuma, Y., and Kaneko, S. (2008) Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J. Hepatol. 49, 207-216
12. Wang, A. G., Yoon, S. Y., Oh, J. H., Jeon, Y. J., Kim, M., Kim, J. M., Byun, S. S., Yang, J. O., Kim, J. H., Kim, D. G., Yeom, Y. I., Yoo, H. S., Kim, Y. S., and Kim, N. S. (2006) Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem. Biophys. Res. Commun. 345, 1022-1032
13. Tietz, P., de Groen, P. C., Anderson, N. L., Sims, C., Esquer-Blasco, R., Meheus, L., Raymackers, J., Dauwe, M., and LaRusso, N. F. (1998) Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database. Electrophoresis 19, 3207-3212
14. Grützmann, R., Pilarsky, C., Ammerpohl, O., Lüttges, J., Böhme, A., Sipos, B., Foerder, M., Alldinger, I., Jahnke, B., Schackert, H. K., Kalthoff, H., Kremer, B., Klöppel, G., and Saeger, H. D. (2004) Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6, 611-622
15. Luzzi, V., Mahadevappa, M., Raja, R., Warrington, J. A., and Watson, M. A. (2003) Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J. Mol. Diagn. 5, 9-14
16. Sriuranpong, V., Mutirangura, A., Gillespie, J. W., Patel, V., Amornphimoltham, P., Molinolo, A. A., Kerekhanjanarong, V., Supanakorn, S., Supiyaphun, P., Rangdaeng, S., Voravud, N., and Gutkind, J. S. (2004) Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin. Cancer Res. 10, 4944-4958
17. Li, C., Hong, Y., Tan, Y. X., Zhou, H., Ai, J. H., Li, S. J., Zhang, L., Xia, Q. C., Wu, J. R., Wang, H. Y., and Zeng, R. (2004) Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol. Cell. Proteomics 3, 399-409
18. Wang, Y., Rudnick, P. A., Evans, E. L., Li, J., Zhuang, Z., Devoe, D. L., Lee, C. S., and Balgley, B. M. (2005) Proteome analysis of microdissected tumor tissue using a capillary isoelectric focusing-based multidimensional separation platform coupled with ESI-tandem MS. Anal. Chem. 77, 6549-6556
19. Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H., McLean, K., McGarvey, K., Knowlton, M., Chen, S., Shu, H., Sahin, A., Kurek, R., Wallwiener, D., Merino, M. J., Petricoin, E. F., 3rd, Zhao, Y., and Steeg, P. S. (2002) Proteomics of human breast ductal carcinoma in situ. Cancer Res. 62, 6740-6749
20. Pasa-Toliæ, L., Lipton, M. S., Masselon, C. D., Anderson, G. A., Shen, Y., Toliæ, N., and Smith, R. D. (2002) Gene expression profiling using advanced mass spectrometric approaches. J. Mass Spectrom. 37, 1185-1198
21. Shen, Y., Toliæ, N., Masselon, C., Pasa-Toliæ, L., Camp, D. G., 2nd, Lipton, M. S., Anderson, G. A., and Smith, R. D. (2004) Nanoscale proteomics. Anal. Bioanal. Chem. 378, 1037-1045
22. Umar, A., Luider, T. M., Foekens, J. A., and Pasa-Toliæ, L. (2007) NanoLC-FT-ICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells. Proteomics 7, 323-329
23. Dos Santos, A., Thiers, V., Sar, S., Derian, N., Bensalem, N., Yilmaz, F., Bralet, M. P., Ducot, B., Brechot, C., and Demaugre, F. (2007) Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis. Proteomics Clin. Appl. 1, 545-554
24. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., and Mann, M. (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466-469 (Pubitemid 126598940)
25. Masselon, C. D., Kieffer-Jaquinod, S., Brugière, S., Dupierris, V., and Garin, J. (2008) Influence of mass resolution on species matching in accurate mass and retention time (AMT) tag proteomics experiments. Rapid Commun. Mass Spectrom. 22, 986-992 (Pubitemid 351468253)
26. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
27. Dupierris, V., Masselon, C., Court, M., Kieffer-Jaquinod, S., and Bruley, C. (2009) A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa. Bioinformatics 25, 1980-1981
28. Monroe, M. E., Toliæ, N., Jaitly, N., Shaw, J. L., Adkins, J. N., and Smith, R. D. (2007) VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Bioinformatics 23, 2021-2023
29. Norbeck, A. D., Monroe, M. E., Adkins, J. N., Anderson, K. K., Daly, D. S., and Smith, R. D. (2005) The utility of accurate mass and LC elution time information in the analysis of complex proteomes. J. Am Soc. Mass Spectrom. 16, 1239-1249
30. Fu, X., Gharib, S. A., Green, P. S., Aitken, M. L., Frazer, D. A., Park, D. R., Vaisar, T., and Heinecke, J. W. (2008) Spectral index for assessment of differential protein expression in shotgun proteomics. J. Proteome Res. 7, 845-854
31. Liu, H., Sadygov, R. G., and Yates, J. R., 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201
32. Kearney, R. E., Blondeau, F., McPherson, P. S., Bell, A. W., Servant, F., Drapeau, M., de Grandpre, S., and Bergeron, J. J. M. (2005) Elimination of redundant protein identifications in high throughput proteomics, in 27th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Shanghai, September 1-4, 2005, Vols. 1-7, pp. 4803-4806, Institute of Electrical and Electronic Engineers (IEEE) Engineering in Medicine and Biology Society, Piscataway, NJ
33. Prakash, A., Piening, B., Whiteaker, J., Zhang, H., Shaffer, S. A., Martin, D., Hohmann, L., Cooke, K., Olson, J. M., Hansen, S., Flory, M. R., Lee, H., Watts, J., Goodlett, D. R., Aebersold, R., Paulovich, A., and Schwikowski, B. (2007) Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomics. Mol. Cell. Proteomics 6, 1741-1748 (Pubitemid 350031675)
34. Becker, R., Lenter, M. C., Vollkommer, T., Boos, A. M., Pfaff, D., Augustin, H. G., and Christian, S. (2008) Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. FASEB J. 22, 3059-3067
35. Koopmann, J., Thuluvath, P. J., Zahurak, M. L., Kristiansen, T. Z., Pandey, A., Schulick, R., Argani, P., Hidalgo, M., Iacobelli, S., Goggins, M., and Maitra, A. (2004) Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 101, 1609-1615 (Pubitemid 39318908)
36. Schmidt, V. A., Chiariello, C. S., Capilla, E., Miller, F., and Bahou, W. F. (2008) Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Mol. Cell. Biol. 28, 1489-1502
37. White, C. D., Brown, M. D., and Sacks, D. B. (2009) IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett. 583, 1817-1824
38. Furubo, S., Harada, K., Shimonishi, T., Katayanagi, K., Tsui, W., and Nakanuma, Y. (1999) Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. Histopathology 35, 230-240 (Pubitemid 29468957)
39. Momoi, H., Okabe, H., Kamikawa, T., Satoh, S., Ikai, I., Yamamoto, M., Nakagawara, A., Shimahara, Y., Yamaoka, Y., and Fukumoto, M. (2001) Comprehensive allelotyping of human intrahepatic cholangiocarcinoma. Clin. Cancer Res. 7, 2648-2655 (Pubitemid 32911367)
40. Ohashi, K., Nakajima, Y., Kanehiro, H., Tsutsumi, M., Taki, J., Aomatsu, Y., Yoshimura, A., Ko, S., Kin, T., Yagura, K., Yoichi Konishi and Hiroshige Nakano (1995) Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology 109, 1612-1617
41. Junking, M., Wongkham, C., Sripa, B., Sawanyawisuth, K., Araki, N., and Wongkham, S. (2008) Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur. J. Cancer 44, 619-626
42. Schmitz, K. J., Lang, H., Wohlschlaeger, J., Sotiropoulos, G. C., Reis, H., Schmid, K. W., and Baba, H. A. (2007) AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J. Gastroenterol. 13, 6470-6477
43. Kawase, H., Fujii, K., Miyamoto, M., Kubota, K. C., Hirano, S., Kondo, S., and Inagaki, F. (2009) Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues. J. Proteome Res. 8, 4092-4103
44. Mikuriya, K., Kuramitsu, Y., Ryozawa, S., Fujimoto, M., Mori, S., Oka, M., Hamano, K., Okita, K., Sakaida, I., and Nakamura, K. (2007) Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 30, 849-855
45. Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P. J., and Banks, R. E. (2003) Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3, 1620-1632
46. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
47. Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., and Cantley, L. C. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233
48. Liu, Y., Chen, Q., and Zhang, J. T. (2004) Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J. Proteome Res. 3, 728-735
49. Thomas, P. A., Kirschmann, D. A., Cerhan, J. R., Folberg, R., Seftor, E. A., Sellers, T. A., and Hendrix, M. J. (1999) Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin. Cancer Res. 5, 2698-2703 (Pubitemid 29493942)
50. Wei, J., Xu, G., Wu, M., Zhang, Y., Li, Q., Liu, P., Zhu, T., Song, A., Zhao, L., Han, Z., Chen, G., Wang, S., Meng, L., Zhou, J., Lu, Y., Wang, S., and Ma, D. (2008) Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res. 28, 327-334 (Pubitemid 351362921)
51. Wu, M., Bai, X., Xu, G., Wei, J., Zhu, T., Zhang, Y., Li, Q., Liu, P., Song, A., Zhao, L., Gang, C., Han, Z., Wang, S., Zhou, J., Lu, Y., and Ma, D. (2007) Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression. Proteomics 7, 1973-1983 (Pubitemid 47020332)
52. McInroy, L., and Määttä, A. (2007) Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem. Biophys. Res. Commun. 360, 109-114 (Pubitemid 46990330)
53. Jordan, M. A., and Wilson, L. (1998) Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10, 123-130
54. Pawlak, G., and Helfman, D. M. (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr. Opin. Genet. Dev. 11, 41-47
55. Hall, A. (2009) The cytoskeleton and cancer. Cancer Metastasis Rev. 28, 5-14
56. Yamaguchi, H., and Condeelis, J. (2007) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 1773, 642-652 (Pubitemid 46660177)
57. Yan, B., Yap, C. T., Wang, S., Lee, C. K., Koh, S., Omar, M. F., Salto-Tellez, M., and Kumarasinghe, M. P. (2010) Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors. Acta Histochem. 112, 101-106
58. Janke, J., Schlüter, K., Jandrig, B., Theile, M., Kölble, K., Arnold, W., Grinstein, E., Schwartz, A., Estevéz-Schwarz, L., Schlag, P. M., Jockusch, B. M., and Scherneck, S. (2000) Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J. Exp. Med. 191, 1675-1686
59. Shields, J. M., Rogers-Graham, K., and Der, C. J. (2002) Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J. Biol. Chem. 277, 9790-9799
60. Assinder, S. J., Stanton, J. A., and Prasad, P. D. (2009) Transgelin: an actin-binding protein and tumour suppressor. Int. J. Biochem. Cell Biol. 41, 482-486
61. Wittenmayer, N., Jandrig, B., Rothkegel, M., Schlüter, K., Arnold, W., Haensch, W., Scherneck, S., and Jockusch, B. M. (2004) Tumor suppressor activity of profilin requires a functional actin binding site. Mol. Biol. Cell 15, 1600-1608
62. Heizmann, C. W., Fritz, G., and Schäfer, B. W. (2002) S100 proteins: structure, functions and pathology. Front. Biosci. 7, d1356-1368
63. Schäfer, B. W., and Heizmann, C. W. (1996) The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21, 134-140
64. Chen, J. H., Ni, R. Z., Xiao, M. B., Guo, J. G., and Zhou, J. W. (2009) Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat. Dis. Int. 8, 193-200
65. Melle, C., Ernst, G., Schimmel, B., Bleul, A., Mothes, H., Kaufmann, R., Settmacher, U., and Von Eggeling, F. (2006) Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int. J. Oncol. 28, 195-200
66. Wang, G., Wang, X., Wang, S., Song, H., Sun, H., Yuan, W., Cao, B., Bai, J., and Fu, S. (2008) Colorectal cancer progression correlates with up-regulation of S100A11 expression in tumor tissues. Int. J. Colorectal Dis. 23, 675-682
67. Stulík, J., Hernychová, L., Porkertová, S., Knízek, J., Macela, A., Bures, J., Jandik, P., Langridge, J. I., and Jungblut, P. R. (2001) Proteome study of colorectal carcinogenesis. Electrophoresis 22, 3019-3025
68. Ørntoft, T. F., Thykjaer, T., Waldman, F. M., Wolf, H., and Celis, J. E. (2002) Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol. Cell. Proteomics 1, 37-45
69. Badea, L., Herlea, V., Dima, S. O., Dumitrascu, T., and Popescu, I. (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55, 2016-2027
70. Mohammad, H. S., Kurokohchi, K., Yoneyama, H., Tokuda, M., Morishita, A., Jian, G., Shi, L., Murota, M., Tani, J., Kato, K., Miyoshi, H., Deguchi, A., Himoto, T., Usuki, H., Wakabayashi, H., Izuishi, K., Suzuki, Y., Iwama, H., Deguchi, K., Uchida, N., Sabet, E. A., Arafa, U. A., Hassan, A. T., El-Sayed, A. A., and Masaki, T. (2008) Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int. J. Oncol. 33, 1157-1163
71. Zimmermann, U., Woenckhaus, C., Pietschmann, S., Junker, H., Maile, S., Schultz, K., Protzel, C., and Giebel, J. (2004) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch. 445, 368-374
72. Pena-Alonso, E., Rodrigo, J. P., Parra, I. C., Pedrero, J. M., Meana, M. V., Nieto, C. S., Fresno, M. F., Morgan, R. O., and Fernandez, M. P. (2008) Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett. 263, 89-98
73. Liu, J. W., Shen, J. J., Tanzillo-Swarts, A., Bhatia, B., Maldonado, C. M., Person, M. D., Lau, S. S., and Tang, D. G. (2003) Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22, 1475-1485
74. Gillette, J. M., Chan, D. C., and Nielsen-Preiss, S. M. (2004) Annexin 2 expression is reduced in human osteosarcoma metastases. J. Cell. Biochem. 92, 820-832
75. Rajasekaran, A. K., and Rajasekaran, S. A. (2003) Role of Na-K-ATPase in the assembly of tight junctions. Am. J. Physiol. Renal Physiol. 285, F388-F396
76. Barwe, S. P., Anilkumar, G., Moon, S. Y., Zheng, Y., Whitelegge, J. P., Rajasekaran, S. A., and Rajasekaran, A. K. (2005) Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol. Biol. Cell 16, 1082-1094
77. Fleming, T. P., Ghassemifar, M. R., and Sheth, B. (2000) Junctional complexes in the early mammalian embryo. Semin. Reprod. Med. 18, 185-193
78. Klymkowsky, M. W., and Savagner, P. (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 174, 1588-1593
79. Zavadil, J., and Böttinger, E. P. (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774
80. Levy, L., and Hill, C. S. (2006) Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17, 41-58 (Pubitemid 43117515)
81. Benckert, C., Jonas, S., Cramer, T., Von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., Höcker, M., and Rosewicz, S. (2003) Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res. 63, 1083-1092
82. Zen, Y., Harada, K., Sasaki, M., Chen, T. C., Chen, M. F., Yeh, T. S., Jan, Y. Y., Huang, S. F., Nimura, Y., and Nakanuma, Y. (2005) Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. Lab. Invest. 85, 572-581
83. Keshamouni, V. G., Jagtap, P., Michailidis, G., Strahler, J. R., Kuick, R., Reka, A. K., Papoulias, P., Krishnapuram, R., Srirangam, A., Standiford, T. J., Andrews, P. C., and Omenn, G. S. (2009) Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J. Proteome Res. 8, 35-47
84. Guedj, N., Zhan, Q., Perigny, M., Rautou, P. E., Degos, F., Belghiti, J., Farges, O., Bedossa, P., and Paradis, V. (2009) Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J. Hepatol. 51, 93-101